|
UQCRC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.88720200262105E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.873199538873E-10 |
| Normal-vs-Stage2 |
5.586600E-01 |
| Normal-vs-Stage3 |
9.1097129839568E-12 |
| Normal-vs-Stage4 |
2.47349918325313E-11 |
| Stage1-vs-Stage2 |
9.776000E-03 |
| Stage1-vs-Stage3 |
1.038960E-01 |
| Stage1-vs-Stage4 |
2.892100E-02 |
| Stage2-vs-Stage3 |
1.282890E-03 |
| Stage2-vs-Stage4 |
5.410900E-04 |
| Stage3-vs-Stage4 |
5.600600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11226608321158E-12 |
| Normal-vs-AfricanAmerican |
3.70910000000446E-05 |
| Normal-vs-Asian |
5.35019999969855E-07 |
| Caucasian-vs-AfricanAmerican |
5.411800E-01 |
| Caucasian-vs-Asian |
9.780200E-01 |
| AfricanAmerican-vs-Asian |
5.823800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.66799999660128E-08 |
| Normal-vs-Female |
1.57259982813684E-10 |
| Male-vs-Female |
8.677600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.26159999008979E-09 |
| Normal-vs-Age(41-60Yrs) |
5.02610175701079E-11 |
| Normal-vs-Age(61-80Yrs) |
3.388700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.590200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.856800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.366160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.777800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.087600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.767400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.987200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.998100E-02 |
| Classical-VS-Follicular |
2.633400E-04 |
| Classical-VS-Other |
6.212400E-01 |
| Classical-VS-Normal |
2.1378454562182E-12 |
| Tall-VS-Follicular |
2.00750000000083E-05 |
| Tall-VS-Other |
8.418000E-01 |
| Tall-VS-Normal |
5.84939874315182E-11 |
| Follicular-VS-Other |
1.588610E-01 |
| Follicular-VS-Normal |
2.267000E-01 |
| Other-VS-Normal |
6.595700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.81039999552968E-08 |
| Normal-vs-N1 |
1.4432899320127E-15 |
| N0-vs-N1 |
3.42789999996373E-06 |
|
|
